CWA Asset Management Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.29M | Sell |
|
|||||
|
2025
Q1 | $13M | Buy |
|
|||||
|
2024
Q4 | $7.11M | Buy |
|
|||||
|
2024
Q3 | $6.35M | Buy |
|
|||||
|
2024
Q1 | $1.66M | Buy |
|
|||||
|
2023
Q4 | $1.13M | Sell |
|
|||||
|
2023
Q3 | $1.08M | Buy |
|
|||||
|
2023
Q2 | $1.03M | Buy |
|
|||||
|
2023
Q1 | $1.09M | Buy |
|
|||||
|
2022
Q4 | $963K | Sell |
|
|||||
|
2022
Q3 | $966K | Buy |
|
|||||
|
2022
Q2 | $813K | Buy |
|
|||||
|
2022
Q1 | $449K | Buy |
|
|||||
|
2021
Q4 | $285K | Sell |
|
|||||
|
2021
Q3 | $879K | Buy |
|
|||||
|
2021
Q2 | $791K | Buy |
|
|||||
|
2021
Q1 | $528K | Buy |
|
|||||
|
2020
Q4 | $443K | Sell |
|
|||||
|
2020
Q3 | $2.12M | Buy |
|
|||||
|
2020
Q2 | $1.83M | Buy |
|
|||||
|
2020
Q1 | $1.36M | Buy |
|
|||||
|
2019
Q4 | $392K | Buy |
|
|||||
|
2019
Q3 | $382K | Sell |
|
|||||
|
2019
Q2 | $3.77M | Buy |
|
|||||
|
2019
Q1 | $3.23M | Buy |
|
|||||
|
2018
Q4 | $2.58M | Buy |
|
|||||
|
2018
Q3 | $3.18M | Buy |
|
|||||
|
2018
Q2 | $2.7M | Buy |
|
|||||
|
2018
Q1 | $2.67M | Buy |
|
|||||
|
2017
Q4 | $1.83M | Buy |
|
|||||
|
2017
Q3 | $302K | Buy |
|
|||||
|
2017
Q2 | $263K | Sell |
|
|||||
|
2017
Q1 | $324K | Sell |
|
|||||
|
2016
Q4 | $491K | Buy |
|
|||||
|
2016
Q3 | $350K | Sell |
|
|||||
|
2016
Q2 | $387K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $787K | Buy |
|